Aveanna Healthcare Holdings Inc. (AVAH) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 2, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2027, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AVAH SEC filings page.
Aveanna Healthcare Holdings Inc. (AVAH) reported $2.6B in revenue over the twelve months to Jul 4, 2026, up 19.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Operating leverage and cash conversion are improving, while heavy interest expense keeps reported earnings near break-even.
From FY2023 through FY2026, operating margin expanded from0.4% to10.5% while gross margin moved only from31.4% to33.3% ; the larger change therefore occurred below gross profit, consistent with better operating cost absorption rather than a major margin-mix shift. Operating cash flow also rose to$125.9M in FY2026, but net income was only$225K , showing that the tax benefit and financing costs materially distort the relationship between operating performance and bottom-line earnings.
Cash conversion strengthened: operating cash flow exceeded
The balance sheet moved from negative equity in FY2024 to
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Aveanna Healthcare Holdings Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Aveanna Healthcare Holdings Inc. has an operating margin of 10.5%, meaning the company retains $11 of operating profit per $100 of revenue. This results in a moderate score of 45/100, indicating healthy but not exceptional operating efficiency. This is up from 6.9% the prior year.
Aveanna Healthcare Holdings Inc.'s revenue surged 20.2% year-over-year to $2.4B, reflecting rapid business expansion. This strong growth earns a score of 72/100.
Aveanna Healthcare Holdings Inc. has elevated debt relative to equity (D/E of 6.62), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 15/100, reflecting increased financial risk.
Aveanna Healthcare Holdings Inc.'s current ratio of 1.32 indicates adequate short-term liquidity, earning a score of 34/100. The company can meet its near-term obligations, though with limited headroom.
Not available for Aveanna Healthcare Holdings Inc., and counted as zero in the overall score.
Aveanna Healthcare Holdings Inc.'s ROE of 0.1% shows moderate profitability relative to equity, earning a score of 52/100.
Aveanna Healthcare Holdings Inc. scores 1.81, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($2.7B) relative to total liabilities ($1.8B). This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Aveanna Healthcare Holdings Inc. passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
Aveanna Healthcare Holdings Inc. reported $225K of net income while generating $125.9M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead.
Aveanna Healthcare Holdings Inc. earns $1.83 in operating income for every $1 of interest expense ($256.5M vs $140.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Aveanna Healthcare Holdings Inc. generated $670.5M in revenue in Q2 2027. This represents an increase of 13.7% from the same quarter a year earlier. Against the prior quarter it is up 3.5%.
Aveanna Healthcare Holdings Inc.'s EBITDA was $82.8M in Q2 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 0.2% from the same quarter a year earlier. Against the prior quarter it is up 14.5%.
Aveanna Healthcare Holdings Inc. reported $40.3M in net income in Q2 2027. This represents an increase of 49.1% from the same quarter a year earlier. Against the prior quarter it is down 3.3%.
Aveanna Healthcare Holdings Inc. earned $0.18 per diluted share (EPS) in Q2 2027. This represents an increase of 38.5% from the same quarter a year earlier. Against the prior quarter it is down 5.3%.
Cash & Balance Sheet
Aveanna Healthcare Holdings Inc. held $97.2M in cash against $1.3B in long-term debt as of Q2 2027.
Not reported for Q2 2027.
Not reported for Q2 2027.
Margins & Returns
Aveanna Healthcare Holdings Inc.'s gross margin was 32.6% in Q2 2027, indicating the percentage of revenue retained after direct costs. This is down 3.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.9 percentage points.
Aveanna Healthcare Holdings Inc.'s operating margin was 11.9% in Q2 2027, reflecting core business profitability. This is down 1.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.2 percentage points.
Aveanna Healthcare Holdings Inc.'s net profit margin was 6.0% in Q2 2027, showing the share of revenue converted to profit. This is up 1.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.4 percentage points.
Aveanna Healthcare Holdings Inc.'s ROE was 14.0% in Q2 2027, measuring profit generated per dollar of shareholder equity. Against the prior quarter it is down 3.3 percentage points.
Capital Allocation
None of these metrics is reported for Q2 2027.
AVAH Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2710-Q | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $670.5M+13.7% | $647.9M+15.9% | $662.5M+27.4% | $621.9M+22.2% | $589.6M+16.8% | $559.2M+14.0% | $519.9M+8.6% | $509.0M+6.5% |
| Cost of Revenue | $452.0M+19.3% | $442.5M+17.8% | $449.2M+29.0% | $419.1M+20.0% | $378.8M+9.2% | $375.7M+9.0% | $348.1M+5.4% | $349.3M+5.6% |
| Gross Profit | $218.5M+3.7% | $205.4M+11.9% | $213.3M+24.2% | $202.8M+27.0% | $210.8M+33.2% | $183.6M+25.9% | $171.7M+15.7% | $159.7M+8.4% |
| SG&A Expenses | $97.1M+7.8% | $95.8M+4.8% | $97.6M+10.0% | $95.4M+8.2% | $90.1M+2.4% | $91.4M+4.0% | $88.7M+2.0% | $88.2M-3.1% |
| Operating Income | $80.0M-0.1% | $69.3M+33.8% | $71.0M+55.2% | $53.6M+57.5% | $80.0M+115.6% | $51.8M+126.5% | $45.8M+56.3% | $34.0M+144.6% |
| EBITDA | $82.8M+0.2% | $72.4M+33.0% | $73.8M+53.0% | $56.2M+53.5% | $82.7M+106.8% | $54.4M+111.0% | $48.2M+48.0% | $36.6M+149.9% |
| Interest Expense | $27.8M-22.9% | $29.2M-19.8% | $32.6M-14.4% | $35.1M-10.5% | $36.0M-9.1% | $36.3M-8.4% | $38.1M-4.0% | $39.2M-0.9% |
| Income Tax | $16.2M-5.5% | $3.3M-33.0% | -$139.5M-6114.1% | -$647K-104.2% | $17.1M+272.4% | $5.0M-60.9% | -$2.2M+61.7% | $15.5M+2358.2% |
| Net Income | $40.3M+49.1% | $41.7M+702.1% | -$46.1M-214.9% | $14.1M+132.8% | $27.0M+94.3% | $5.2M+146.5% | $40.1M-63.1% | -$42.8M+58.2% |
| EPS (Basic) | $0.19+46.2% | $0.19+533.3% | $0.88+486.7% | $0.07+131.8% | $0.13+85.7% | $0.03+150.0% | $0.15+207.1% | -$0.22+59.3% |
| EPS (Diluted) | $0.18+38.5% | $0.19+533.3% | $0.83+453.3% | $0.06+127.3% | $0.13+85.7% | $0.03+150.0% | $0.15+207.1% | -$0.22+59.3% |
| Diluted Shares (Avg) | 225M+6.9% | 222M+7.7% | N/A | 222M+14.9% | 210M+6.9% | 206M+7.3% | N/A | 193M+2.2% |
Not reported in any period shown, so not listed: R&D Expenses.
AVAH Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2710-Q | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.1B+18.9% | $2.0B+21.8% | $2.0B+21.0% | $1.8B+10.1% | $1.8B+6.4% | $1.7B+1.1% | $1.7B+3.1% | $1.6B-0.6% |
| Current Assets | $478.1M+6.3% | $575.3M+41.1% | $560.2M+42.7% | $502.6M+31.8% | $449.9M+23.6% | $407.6M+21.3% | $392.7M+24.7% | $381.4M+19.8% |
| Cash & Equivalents | $97.2M-3.5% | $189.3M+164.7% | $193.3M+129.3% | $145.9M+85.9% | $100.7M+111.4% | $71.5M+67.8% | $84.3M+91.8% | $78.5M+62.5% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | $337.2M+6.6% | $332.7M+12.8% | $313.4M+18.2% | $312.8M+17.8% | $316.3M+15.9% | $294.8M+14.5% | $265.2M+12.1% | $265.4M+12.6% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $1.3B+14.1% | $1.1B+6.3% | $1.1B+6.3% | $1.1B+5.9% | $1.1B+6.1% | $1.1B0.0% | $1.1B0.0% | $1.1B0.0% |
| Total Liabilities | $1.8B+2.0% | $1.8B+1.2% | $1.8B+1.8% | $1.8B+0.1% | $1.8B0.0% | $1.8B-1.0% | $1.8B+2.6% | $1.8B+2.3% |
| Current Liabilities | $411.3M-0.7% | $390.4M+0.5% | $424.5M+5.5% | $409.7M+0.9% | $414.2M+6.4% | $388.3M+1.7% | $402.2M+13.4% | $406.0M+11.5% |
| Non-Current Liabilities | $1.4B+2.9% | $1.4B+1.4% | $1.4B+0.7% | $1.4B-0.2% | $1.4B-1.8% | $1.4B-1.7% | $1.4B-0.2% | $1.4B-0.1% |
| Long-Term Debt | $1.3B+1.2% | $1.3B+1.1% | $1.3B+1.2% | $1.3B+1.1% | $1.3B-0.3% | $1.3B-0.4% | $1.3B-0.4% | $1.3B-0.2% |
| Total Equity | $287.3M+2495.6% | $240.1M+339.7% | $194.5M+257.4% | $9.2M+105.9% | -$12.0M+89.9% | -$100.1M+26.5% | -$123.6M+4.6% | -$156.4M-48.0% |
| Retained Earnings | -$1.1B+20.4% | -$1.1B+19.0% | -$1.2B+16.3% | -$1.3B+5.3% | -$1.3B+1.4% | -$1.4B+0.4% | -$1.4B-0.8% | -$1.4B-4.9% |
Not reported in any period shown, so not listed: Inventory.
AVAH Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2710-Q | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $80.9M+56.9% | $4.3M+150.4% | $49.7M+270.9% | $33.2M+12.9% | $51.6M+2750.7% | -$8.6M+27.9% | $13.4M+546.1% | $29.4M+2.4% |
| Depreciation & Amortization | $2.8M+8.9% | $3.0M+17.3% | $2.7M+11.5% | $2.6M+0.5% | $2.6M-7.6% | $2.6M-10.9% | $2.4M-25.5% | $2.6M-12.7% |
| Stock-Based Compensation | N/A | $4.1M-62.3% | N/A | N/A | N/A | $11.0M+169.4% | N/A | N/A |
| Investing Cash Flow | -$175.4M-997.3% | -$4.6M-94.1% | -$1.9M-27.5% | -$2.0M+8.8% | -$16.0M-1159.4% | -$2.3M-79.5% | -$1.5M+2.5% | -$2.2M-96.4% |
| Financing Cash Flow | $2.4M+137.2% | -$3.8M-108.3% | -$377K+93.8% | $13.9M+285.3% | -$6.3M-240.5% | -$1.8M-115.2% | -$6.1M-2838.0% | $3.6M+149.7% |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
AVAH Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2710-Q | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 32.6%-3.2pp | 31.7%-1.1pp | 32.2%-0.8pp | 32.6%+1.2pp | 35.8%+4.4pp | 32.8%+3.1pp | 33.0%+2.0pp | 31.4%+0.6pp |
| Operating Margin | 11.9%-1.7pp | 10.7%+1.4pp | 10.7%+1.9pp | 8.6%+1.9pp | 13.6%+6.2pp | 9.3%+4.6pp | 8.8%+2.7pp | 6.7%+22.7pp |
| Net Margin | 6.0%+1.4pp | 6.4%+5.5pp | -7.0%-14.7pp | 2.3%+10.7pp | 4.6%+1.8pp | 0.9%+3.2pp | 7.7%-15.0pp | -8.4%+13.0pp |
| Return on Equity | 14.0% | 17.3% | -23.7% | 153.1% | N/A | N/A | N/A | N/A |
| Return on Assets | 1.9%+0.4pp | 2.1%+1.8pp | -2.3%-4.7pp | 0.8%+3.4pp | 1.5%+0.7pp | 0.3%+1.0pp | 2.4%-4.3pp | -2.6%+3.6pp |
| Current Ratio | 1.16+0.1x | 1.47+0.4x | 1.32+0.3x | 1.23+0.3x | 1.09+0.2x | 1.05+0.2x | 0.98+0.1x | 0.94+0.1x |
| Debt-to-Equity | 4.47 | 5.35 | 6.62 | 140.39 | N/A | N/A | N/A | N/A |
| Asset Turnover | 0.320.0x | 0.320.0x | 0.330.0x | 0.340.0x | 0.330.0x | 0.340.0x | 0.310.0x | 0.310.0x |
Not reported in any period shown, so not listed: FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Aveanna Healthcare Holdings Inc. AVAH | FY2026 | $2.4B | $225K | 0.0% | $2.7B | 36/100 |
| National Healthcare Corp. NHC | FY2025 | $1.5B | $120.0M | 7.9% | $3.5B | 67/100 |
| Ardent Health, Inc. ARDT | FY2025 | $6.3B | $135.8M | 2.1% | $1.4B | 28/100 |
| Brookdale Senior Living, Inc. BKD | FY2025 | $3.2B | -$262.7M | -8.2% | $2.6B | 25/100 |
| P3 Health Partners Inc. PIII | FY2025 | $1.5B | -$147.9M | -10.1% | $24.5M | 24/100 |
| SELECT MEDICAL HOLDINGS CORP SEM | FY2025 | $5.5B | $146.2M | 2.7% | $2.0B | 40/100 |
Where Aveanna Healthcare Holdings Inc. Ranks
Frequently Asked Questions
What is Aveanna Healthcare Holdings Inc.'s annual revenue?
Aveanna Healthcare Holdings Inc. (AVAH) reported $2.4B in total revenue for fiscal year 2026. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is Aveanna Healthcare Holdings Inc. profitable?
Yes, Aveanna Healthcare Holdings Inc. (AVAH) reported a net income of $225K in fiscal year 2026, with a net profit margin of 0.0%.
What is Aveanna Healthcare Holdings Inc.'s EBITDA?
Aveanna Healthcare Holdings Inc. (AVAH) had EBITDA of $267.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Aveanna Healthcare Holdings Inc. have?
As of fiscal year 2026, Aveanna Healthcare Holdings Inc. (AVAH) had $193.3M in cash and equivalents against $1.3B in long-term debt.
What is Aveanna Healthcare Holdings Inc.'s gross margin?
Aveanna Healthcare Holdings Inc. (AVAH) had a gross margin of 33.3% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Aveanna Healthcare Holdings Inc.'s operating margin?
Aveanna Healthcare Holdings Inc. (AVAH) had an operating margin of 10.5% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is Aveanna Healthcare Holdings Inc.'s net profit margin?
Aveanna Healthcare Holdings Inc. (AVAH) had a net profit margin of 0.0% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
What is Aveanna Healthcare Holdings Inc.'s return on equity (ROE)?
Aveanna Healthcare Holdings Inc. (AVAH) has a return on equity of 0.1% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Aveanna Healthcare Holdings Inc.'s operating cash flow?
Aveanna Healthcare Holdings Inc. (AVAH) generated $125.9M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Aveanna Healthcare Holdings Inc.'s total assets?
Aveanna Healthcare Holdings Inc. (AVAH) had $2.0B in total assets as of fiscal year 2026, including both current and long-term assets.
What is Aveanna Healthcare Holdings Inc.'s current ratio?
Aveanna Healthcare Holdings Inc. (AVAH) had a current ratio of 1.32 as of fiscal year 2026, which is considered adequate.
What is Aveanna Healthcare Holdings Inc.'s debt-to-equity ratio?
Aveanna Healthcare Holdings Inc. (AVAH) had a debt-to-equity ratio of 6.62 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Aveanna Healthcare Holdings Inc.'s return on assets (ROA)?
Aveanna Healthcare Holdings Inc. (AVAH) had a return on assets of 0.0% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Aveanna Healthcare Holdings Inc.'s P/E ratio?
Aveanna Healthcare Holdings Inc. (AVAH) trades at 55.0x earnings, its market capitalization divided by net income of $50.0M net income, trailing 12 months to July 4, 2026. The market capitalization is $2.7B as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Aveanna Healthcare Holdings Inc.'s price-to-sales ratio?
Aveanna Healthcare Holdings Inc. (AVAH) trades at 1.1x sales, its market capitalization divided by revenue of $2.6B revenue, trailing 12 months to July 4, 2026. The market capitalization is $2.7B as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Aveanna Healthcare Holdings Inc.'s Altman Z-Score?
Aveanna Healthcare Holdings Inc. (AVAH) has an Altman Z-Score of 1.81, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Aveanna Healthcare Holdings Inc.'s Piotroski F-Score?
Aveanna Healthcare Holdings Inc. (AVAH) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Aveanna Healthcare Holdings Inc.'s earnings high quality?
Aveanna Healthcare Holdings Inc. (AVAH) reported $225K of net income while generating $125.9M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Aveanna Healthcare Holdings Inc. cover its interest payments?
Aveanna Healthcare Holdings Inc. (AVAH) has an interest coverage ratio of 1.83x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Aveanna Healthcare Holdings Inc.?
Aveanna Healthcare Holdings Inc. (AVAH) scores 36 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.